A hypoxia-activated copper ion nanoexchanger for cancer immunotherapy by in situ precise production of immunogenic cell death inducer DOI
Xinlu Zhang, Yongxin Liu, Huan Li

et al.

Chinese Chemical Letters, Journal Year: 2025, Volume and Issue: unknown, P. 111404 - 111404

Published: June 1, 2025

Language: Английский

Biomimetic Nanoparticles for Targeted Lung Cancer Immunotherapy via Specific Clearance of High Potassium DOI Creative Commons

Jiaqi You,

Jie Shen, Wenwen Liu

et al.

ACS Applied Nano Materials, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 18, 2025

Language: Английский

Citations

0

Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy DOI Creative Commons
Abdullah F. U. H. Saeed

Cells, Journal Year: 2025, Volume and Issue: 14(10), P. 741 - 741

Published: May 19, 2025

Tumor-associated macrophages’ (TAMs) origin, polarization, and dynamic interaction in the tumor microenvironment (TME) influence cancer development. They are essential for homeostasis, monitoring, immune protection. Cells from bone marrow or embryonic progenitors dynamically polarize into pro- anti-tumor M2 M1 phenotypes based on cytokines metabolic signals. Recent advances TAM heterogeneity, characterization, immunological responses, therapy described here. The manuscript details functions their role resistance to PD-1/PD-L1 blockade. Similarly, TAM-targeted approaches, such as CSF-1R inhibition PI3Kγ-driven reprogramming, discussed address immunity suppression. Furthermore, innovative biomarkers combination may enhance TAM-centric therapies. It also stresses relevance of this distinct cell human health disease, which could impact future research

Language: Английский

Citations

0

Nanovaccines: Antigen selection, stabilization, adjuvantation, formulation, and evaluation DOI
Lisen Lu, Muyang Yang,

Deqiang Deng

et al.

Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 541, P. 216806 - 216806

Published: May 21, 2025

Language: Английский

Citations

0

Cryo‐Inactivated Cancer Cells Derived Magnetic Micromotors for Tumor Immunotherapy DOI Creative Commons
Qingfei Zhang, Gaizhen Kuang, Wenzhao Li

et al.

Advanced Science, Journal Year: 2025, Volume and Issue: unknown

Published: May 23, 2025

Abstract Immunotherapy represents a highly promising modality in cancer treatment, with substantial advancements therapeutic strategies. The primary challenge lies enhancing the efficacy of immunotherapy approaches. Here, novel cryo‐inactivated cells (CICC) derived magnetic micromotors (CICC@FeMnP) are reported for tumor synergistic immunotherapy. Through control, CICC@FeMnP can on‐demand target and accumulate at site. FeMnP induce ferroptosis then trigger immunogenic cell death cells. CICC containing whole antigen conduct vaccination effects. Together Mn 2+ ‐mediated cGAS‐STING pathway to stimulate immune response, anti‐tumor effects be achieved. Importantly, not only facilitate establishment collaborative network enhance effective tumoricidal immunity but also long‐lasting memory These results contribute inhibition progression, recurrence lung metastasis, thereby prolonging overall survival tumor‐bearing mice. This work underscores potential an engineered biohybrid micromotor system as alternative approach against tumors.

Language: Английский

Citations

0

Lymphocyte‐Mimicking Sonosensitizers Boost Cancer Immunotherapy via Sequential Ultrasound Activation DOI
Jiawei Zhu, Xiaorui Wang, Runtao Li

et al.

Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown

Published: May 24, 2025

Abstract Effective initiation of the cancer‐immunity cycle is core challenge tumor immunotherapy, which relies on coordinated antigen release and immunostimulation. To address this issue, work introduced a novel lymphocyte‐mimicking sonosensitizer using Mn‐doped hollow Prussian blue nanoparticle (Mn‐HP) for cancer sonodynamic therapy (SDT) to efficiently evoke anticancer immunity. The prepared Mn‐HP have unique architecture amplify ultrasonic cavitation effects, boosting spatially controlled reactive oxygen species (ROS) production. Through effective combination lymphocytes, Lymphocyte‐mimicking (Lymphocytes‐Mn‐HP, LM) with “Homing effect” constructed. sequenced dual‐ultrasound strategy employs high‐power ultrasound (2.0 W cm −2 ) stimulation (excessive ROS) low‐power (0.5 (moderate lymph node active immune cells, enabling precise spatial‐temporal ROS generation while preserving function. Both in vitro vivo studies demonstrated significant suppression through initiating cycle, offering transformative paradigm SDT‐immunotherapy integration.

Language: Английский

Citations

0

Decoding the Metabolic-Immune Axis: Neutrophil Glycolysis-Driven Tumor Niche Remodeling and Its Therapeutic Exploitation DOI Creative Commons
Mengqing Ma, Rui Hu, Qi Huang

et al.

Pharmacological Research, Journal Year: 2025, Volume and Issue: unknown, P. 107811 - 107811

Published: June 1, 2025

Neutrophils are an important component of the tumor microenvironment, with majority previous research concentrating on their anti-tumor role. Recent indicates that elevated neutrophil-lymphocyte ratios indicative worse cancer prognoses. In addition, it revealed functional transition neutrophils related metabolic regulation within microenvironment.The metabolic-immune axis has emerged as a master regulator progression, yet role neutrophil-centric crosstalk in this paradigm remains enigmatic. Therefore, study highlights innovative tumorigenesis, particularly regulatory effect niche transformation after glucose metabolism reprogramming. Simultaneously, we discussed how microenvironment alters neutrophils, influences life cycle, and modifies localization activity inside niche. targeted including new therapies clinical trials, offer possibilities for treatment. This work establishes neutrophil glycolysis linchpin ecosystem provides combinatorial therapeutic blueprint to dismantle pro-tumorigenic niches.

Language: Английский

Citations

0

A hypoxia-activated copper ion nanoexchanger for cancer immunotherapy by in situ precise production of immunogenic cell death inducer DOI
Xinlu Zhang, Yongxin Liu, Huan Li

et al.

Chinese Chemical Letters, Journal Year: 2025, Volume and Issue: unknown, P. 111404 - 111404

Published: June 1, 2025

Language: Английский

Citations

0